anmelden
FTSE All-Share
5.832,63
PKT
+38,13
PKT
+0,66
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.10.22 | Barclays Outperform | Credit Suisse Group | |
| 27.10.22 | Unilever Equal Weight | Barclays Capital | |
| 27.10.22 | AstraZeneca Overweight | Barclays Capital | |
| 27.10.22 | Lloyds Banking Group Buy | Goldman Sachs Group Inc. | |
| 27.10.22 | Unilever Outperform | Bernstein Research | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 27.10.22 | Barclays Buy | Goldman Sachs Group Inc. | |
| 27.10.22 | Barclays Hold | Deutsche Bank AG | |
| 27.10.22 | HSBC Hold | Deutsche Bank AG | |
| 27.10.22 | Standard Chartered Buy | Deutsche Bank AG | |
| 27.10.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 27.10.22 | Barclays Sector Perform | RBC Capital Markets | |
| 26.10.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 26.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.10.22 | Barclays Buy | Jefferies & Company Inc. | |
| 26.10.22 | HSBC Neutral | Credit Suisse Group | |
| 26.10.22 | HSBC Overweight | Barclays Capital | |
| 26.10.22 | Standard Chartered Buy | UBS AG | |
| 26.10.22 | Barclays Buy | UBS AG | |
| 26.10.22 | HSBC Hold | Deutsche Bank AG | |
| 26.10.22 | Barclays Neutral | JP Morgan Chase & Co. | |
| 25.10.22 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 25.10.22 | GSK Hold | Deutsche Bank AG | |
| 25.10.22 | HSBC Outperform | RBC Capital Markets | |
| 25.10.22 | HSBC Buy | UBS AG | |
| 25.10.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 25.10.22 | HSBC Hold | Jefferies & Company Inc. | |
| 24.10.22 | Diageo Overweight | Barclays Capital | |
| 24.10.22 | Unilever Sell | UBS AG | |
| 24.10.22 | GSK Equal Weight | Barclays Capital | |
| 24.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.10.22 | AstraZeneca Neutral | Credit Suisse Group | |
| 21.10.22 | GSK Neutral | UBS AG | |
| 20.10.22 | HSBC Outperform | RBC Capital Markets | |
| 19.10.22 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.22 | Rio Tinto Hold | Deutsche Bank AG | |
| 19.10.22 | Vodafone Group Outperform | Credit Suisse Group | |
| 19.10.22 | Rio Tinto Buy | Goldman Sachs Group Inc. |
